News

Merck Wilmington Biotech will serve as a launch and commercial production facility and the future U.S. home for KEYTRUDA RAHWAY, N.J., April 29, 2025--(BUSINESS WIRE)--Merck (NYSE: MRK), known as ...
AXPAXLI™ (axitinib intravitreal hydrogel, also known as OTX-TKI), Ocular’s investigational product candidate for retinal disease, is based on its ELUTYX™ proprietary bioresorbable hydrogel ...
prostate cancer therapy Xtandi (enzalutamide), and Inlyta (axitinib) for kidney cancer. That shift could protect the company from some of the price-cutting measures in the Inflation Reduction Act ...
for Bavencio in combination with Pfizer’s tyrosine kinase inhibitor Inlyta (axitinib). “Strategically for Precigen, this evolution supports our vision and transition from an exclusive channel ...
AXPAXLI™ (axitinib intravitreal hydrogel, also known as OTX-TKI), Ocular’s investigational product candidate for retinal disease, is based on its ELUTYX™ proprietary bioresorbable hydrogel-based ...
“Placental growth factor (PlGF) is an angiogenic blood biomarker used for pre-eclampsia diagnosis. We have established the Plasmonic Fiber Optic Absorbance Biosensor (P-FAB) technology to detect PlGF ...
They focussed on Placental growth factor (PlGF) -- an angiogenic blood biomarker used widely for the diagnosis of preeclampsia. “The P-FAB technology was able to detect PlGF at a femtomolar level ...
In the 2 nd line setting, 18 cases were treated with cabozantinib, 17 with axitinib, and 7 with other drugs. Patients without primary resistance disease (i.e., non-PRD) had significantly superior ...
At close: April 28 at 4:00:01 PM EDT ...